Restoring Nerve Function
Solaxa is a clinical-stage biopharmaceutical company developing treatments for
rare neurodegenerative disease and nerve injury.
We are pursuing both novel and reformulated drugs to
restore nerve function by targeting ion channels.
Our Company: By The Numbers
9
Different ataxias have shown treatment response with drug
13
5 issued and 8 pending US, EU, Canada patents exclusively licensed
240
Cerebellar ataxia patients studied with drug
$12M+
Non-dilutive NIH & DoD grants to co-founders
20+
Peer-reviewed publications by co-founders